Seroprevalence of Adeno-Associated Virus Neutralizing Antibodies in Males with Duchenne Muscular Dystrophy-Reference-Cited by-同舟云学术

Seroprevalence of Adeno-Associated Virus Neutralizing Antibodies in Males with Duchenne Muscular Dystrophy

Published:2022-12-19 Issue: Volume: Page:
ISSN:1043-0342
Container-title:Human Gene Therapy
language:en
Short-container-title:Human Gene Therapy

Author:

Verma Sumit¹,Nwosu Stella N.¹,Razdan Raj¹,Upadhyayula Saila R.¹,Phan Han C.²,Koroma Abubakarr A.³,Leguizamo Isai³,Correa Natalie S.³,Kuipa Michael³,Lee David³,Vanderford Thomas H.³,Gardner Matthew R.³⁴^ORCID

Affiliation:

1. Department of Pediatric Neurology and Neurosciences, Children's Healthcare of Atlanta, and Emory University School of Medicine, Atlanta, Georgia, USA

2. Department of Pediatric Neurology, The University of Alabama at Birmingham, Birmingham, Alabama, USA

3. Division of Microbiology and Immunology, Emory National Primate Research Center, Emory University, Atlanta, Georgia, USA

4. Division of Infectious Diseases, Department of Medicine, Emory University, Atlanta, Georgia, USA.

Publisher

Mary Ann Liebert Inc

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

https://www.liebertpub.com/doi/pdf/10.1089/hum.2022.081

Reference25 articles.

1. Duchenne and Becker Muscular Dystrophies

2. Current Clinical Applications of In Vivo Gene Therapy with AAVs